Carson Wealth (CWM LLC)
RAPP

Carson Wealth (CWM LLC)’s Rapport Therapeutics RAPP Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$46.2K Buy
1,475
+7
+0.5% +$197 ﹤0.01% 3879
2025
Q4 		$45K Buy
1,468
+10
+0.7% +$277 ﹤0.01% 3684
2025
Q3 		$43K Buy
1,458
+154
+12% +$2.75K ﹤0.01% 3652
2025
Q2 		$15K Buy
1,304
+306
+31% +$3.25K ﹤0.01% 4098
2025
Q1 		$10K Buy
998
+987
+8,973% +$12.8K ﹤0.01% 4125
2024
Q4 		$0 Buy
+11
New +$244 ﹤0.01% 5219

Other funds holding RAPP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $498M AUM 267.53% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Carson Wealth (CWM LLC)'s RAPP Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Rapport Therapeutics (RAPP) stake by 0.48% in Q1 2026, buying an estimated $197 and bringing the position to 1,475 shares worth $46.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3879.

Carson Wealth (CWM LLC) first reported a position in RAPP in Q4 2024 and has held it in 6 quarters since. 147 funds tracked by Wall St. Rank hold RAPP as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,475 shares of Rapport Therapeutics worth $46.2K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 7 Rapport Therapeutics shares in Q1 2026, an estimated $197.
  • Rapport Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3879 holding.
  • Carson Wealth (CWM LLC) first reported a position in Rapport Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 147 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.